1Evers-Kiebooms G,Nys K,Harper P,et al.Preditive DNA-testing for Huntington's disease and reproductive decision making:a Eu ropean collaborative study.Eur J Hum Genet,2002,10 (3):167-176.
2Arango-Lasprilla JC,Iglesias-Dorado J,Lopera F.Clinical and neuropsychological characteristics of Huntington's disease:a review.Rev Neurol,2003,37(8):758-765.
3Leroi I,O Hearn E,Marsh L,et al.Psychopathology in degenerative cerbellar disease:a comparison to Huntington's disease and normal controls.Am J Psychiatry,2002,159(8):1306-1314.
4Paulsen JS,Hoth KF,Nehl C,et al.Critical Periods of Suicide Risk in Huntington's Disease.Am J Psychiatry,2005,162 (4):725-731.
5Fennema-Notestine C,Archibald SL,Jacobson NW,et al.In vivo evidence of cerebellar atrophy and cerebral white matter loss in Huntington disease.Neurology,2004,63 (6),989-995.
6Rubinsztein DC,Leggo J,Coles R,et al.Phenotypic characterization of individuals with 30～40 CAG repeats and apparently normal elderly individuals with 36～39 repeats.Am J Hum Genet,1996,59(1):16-22.
7Giovannone B,Sabbadini G,Di Maio,et al.Analysis of (CAG)n size heterogeneity in somatic and sperm cell NDNA from intermediate and expanded Huntington disease geng carriers.Hum Mutat,1997,10(6):458-464.
8Djousse B,Knowlton M,Hayden EM,et al.Interaction of normal and expanded CAG repeat size influences age at onset of Huntington disease.Am J Med Genet,2003,119A:279-282.
9Vuillaume I,Vermersch P,Destee A,et al.Genetic polymorphisms adjacent to the CAG repeat influence clinical features at onset in Huntington's disease.J Neurol Neurosurg Psychiatry,1998,64(6):758-762.
10Saleem Q,Roy S,Murgood U,et al.Molecular analysis of Huntington's Disease and linked polymorphisms in the Indian population.Acta Neurol Scand,2003,108(4):281-286.
